pbm glp-1 news Liviniti explains LivLite, the first and only weight loss coverage solution Medicare GLP-1 Bridge: What to

Cancers While preclinical data have raised concerns about GLP1 use and thyroid cancer, a 2025 study by University of Florida researchers found the medications are associated with a 17% lower risk of developing 14 obesity-associated cancers, including endometrial, meningioma and ovarian cancers

Regarding gastric emptying, injectable GLP-1RA generally produces a more pronounced and sustained delay, whereas oral semaglutide shows a modest, early-phase effect that attenuates at steady state [74]

It is important to consult a healthcare professional if you are taking medication or are on chronic treatment

PMID: 38279310

D.ClarinA

The market is anticipated to register a CAGR of 6.9% during 20252031